resveratrol has been researched along with glucagon-like peptide 1 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aujard, F; Blanc, S; Dal-Pan, A | 1 |
| Barra, Y; Barthélemy, S; Burcelin, R; Champion, S; Dao, TM; Drucker, DJ; Klopp, P; Pechere, L; Sérée, E; Serino, M; Vachoux, C; Waget, A | 1 |
| Blaak, EE; Holst, JJ; Knop, FK; Konings, E; Schrauwen, P; Timmers, S | 1 |
| Carlson, OD; de Cabo, R; Doyle, ME; Egan, JM; Farhang, K; Fiori, JL; Gadkaree, SK; González-Mariscal, I; Kim, W; Krzysik-Walker, SM; Mattison, JA; Moaddel, R; Pearson, KJ; Sanghvi, M; Shin, YK | 1 |
| Dash, S; Lewis, GF; Morgantini, C; Xiao, C | 1 |
| Baur, JA; Becker, LB; Guan, Y; Reilly, PM; Sims, CA; Wang, H; Widlund, AL | 1 |
| Bound, MJ; Checklin, HL; Horowitz, M; Jones, KL; Rayner, CK; Standfield, S; Thazhath, SS; Wu, T | 1 |
1 review(s) available for resveratrol and glucagon-like peptide 1
| Article | Year |
|---|---|
New and emerging regulators of intestinal lipoprotein secretion.
Topics: Animals; Apolipoprotein B-100; Apolipoprotein B-48; Atherosclerosis; Bile Acids and Salts; Cholesterol; Chylomicrons; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fats; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Dyslipidemias; Exenatide; Fatty Acids, Nonesterified; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptide-1 Receptor; Humans; Incretins; Insulin; Insulin Resistance; Intestine, Small; Lipoproteins; Microbiota; Peptides; Receptors, Glucagon; Resveratrol; Secretory Rate; Stilbenes; Triglycerides; Venoms | 2014 |
2 trial(s) available for resveratrol and glucagon-like peptide 1
| Article | Year |
|---|---|
Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.
Topics: Antioxidants; Blood Glucose; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Fasting; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Male; Middle Aged; Obesity; Postprandial Period; Resveratrol; Stilbenes; Time Factors; Treatment Outcome | 2013 |
Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial.
Topics: Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Energy Intake; Female; Gastric Emptying; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Postprandial Period; Resveratrol; Stilbenes | 2016 |
4 other study(ies) available for resveratrol and glucagon-like peptide 1
| Article | Year |
|---|---|
Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity.
Topics: Animals; Cheirogaleidae; Energy Intake; Energy Metabolism; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Male; Motor Activity; Pancreatic Polypeptide; Peptide YY; Resveratrol; Satiety Response; Stilbenes; Weight Gain | 2010 |
Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control.
Topics: Animals; Blood Glucose; Dietary Fats; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Intolerance; Inflammation; Intestines; Male; Metagenome; Mice; Mice, Inbred C57BL; Receptors, Glucagon; Resveratrol; Stilbenes; Time Factors | 2011 |
Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.
Topics: Animals; Blood Glucose; Body Weight; Cell Dedifferentiation; Densitometry; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Sucrose; Disease Models, Animal; Fluorescent Antibody Technique; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose Tolerance Test; Glycated Hemoglobin; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Macaca mulatta; Nuclear Proteins; Protective Agents; Resveratrol; Sirtuin 1; Stilbenes; Transcription Factors | 2013 |
Resveratrol ameliorates mitochondrial dysfunction but increases the risk of hypoglycemia following hemorrhagic shock.
Topics: Animals; Blood Glucose; Corticosterone; Glucagon; Glucagon-Like Peptide 1; Hypoglycemia; Insulin; Insulin Resistance; Kidney; Male; Mitochondria; Mitochondria, Liver; Rats, Long-Evans; Reactive Oxygen Species; Resuscitation; Resveratrol; Shock, Hemorrhagic; Stilbenes | 2014 |